160 related articles for article (PubMed ID: 12878509)
1. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
3. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
Cottagnoud P; Cottagnoud M; Acosta F; Flatz L; Kühn F; Stucki A; Entenza J
Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):656-62. PubMed ID: 14557920
[TBL] [Abstract][Full Text] [Related]
4. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
5. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
[TBL] [Abstract][Full Text] [Related]
6. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
Croisier D; Chavanet P; Lequeu C; Ahanou A; Nierlich A; Neuwirth C; Piroth L; Duong M; Buisson M; Portier H
J Antimicrob Chemother; 2002 Sep; 50(3):349-60. PubMed ID: 12205059
[TBL] [Abstract][Full Text] [Related]
8. Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin.
Cottagnoud P; Johnson M; Cottagnoud M; Piddock L
Antimicrob Agents Chemother; 2005 Aug; 49(8):3517-9. PubMed ID: 16048972
[TBL] [Abstract][Full Text] [Related]
9. Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Allen GP; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 2003 Aug; 47(8):2606-14. PubMed ID: 12878526
[TBL] [Abstract][Full Text] [Related]
10. Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae.
Shah PM
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():61-5. PubMed ID: 10404340
[TBL] [Abstract][Full Text] [Related]
11. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
12. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
Lister PD
Postgrad Med; 2008 Sep; 120(3 Suppl 1):46-52. PubMed ID: 18931471
[TBL] [Abstract][Full Text] [Related]
15. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
[TBL] [Abstract][Full Text] [Related]
16. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
George J; Morrissey I
J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
[TBL] [Abstract][Full Text] [Related]
18. Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.
Croisier D; Etienne M; Bergoin E; Charles PE; Lequeu C; Piroth L; Portier H; Chavanet P
Antimicrob Agents Chemother; 2004 May; 48(5):1699-707. PubMed ID: 15105123
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin-resistant pneumococcus.
Klugman KP
Clin Infect Dis; 2000 Aug; 31(2):626-7. PubMed ID: 10987743
[No Abstract] [Full Text] [Related]
20. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]